Table 3.

Complications (event rate per patient year) for the total cohort (n = 268)

Clinical data			Complications
				Events	Event rate
Patient years—total	510	Cardiac arrhythmia—SVT		129	0.25
Patient years—HM-II	380	Cardiac arrhythmia—VT		180	0.35
Patient years—HVAD	99	Device malfunction—major		50	0.1
Patient years—HM 3	30	Device malfunction—minor		83	0.16
30-day mortality (%)	7.8	Haemolysis—major		76	0.15
90-day mortality (%)	11.2	Haemolysis—minor		131	0.26
Hospitalisation (days, mean ± SD)	50 ± 36	Hepatic dysfunction		68	0.13
Postoperative data		Hypertension		8	0.02
ICU stay (days, mean ± SD)	11 ± 12	Major bleeding—ENT		15	0.03
Ventilator (days, mean ± SD)	5.5 ± 9.7	Major bleeding—GI		72	0.14
Inotropics (days, mean ± SD)	5.8 ± 7.2	Major bleeding—other		174	0.34
		Major infection—exit site		82	0.16
		Major infection—pocket		15	0.03
		Major infection—sepsis		103	0.2
		Haemorrhagic stroke		25	0.05
		Ischaemic stroke		51	0.1
		Neurological dysfunction—TIA		30	0.06
		Pericardial fluid effusion		41	0.08
		Renal dysfunction—acute		50	0.1
		Renal dysfunction—chronic		4	0.01
		Respiratory failure		76	0.15
		Right heart failure		116	0.23

SVT supraventricular tachycardia, VT ventricular tachycardia, HM-II HeartMate II, HM 3 HeartMate 3, major bleeding—ENT major bleeding in the ear-nose-throat region, major bleeding—GI major gastro-intestinal bleeding, TIA transient ischaemic attack